|
CH587021A5
(cg-RX-API-DMAC10.html)
|
1974-06-07 |
1977-04-29 |
Nestle Sa |
|
|
EP0173552B1
(en)
|
1984-08-24 |
1991-10-09 |
The Upjohn Company |
Recombinant dna compounds and the expression of polypeptides such as tpa
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US5651991A
(en)
|
1987-10-28 |
1997-07-29 |
Nippon Shinyaku Co. Ltd. |
Drug carriers
|
|
US5549910A
(en)
|
1989-03-31 |
1996-08-27 |
The Regents Of The University Of California |
Preparation of liposome and lipid complex compositions
|
|
US5252334A
(en)
|
1989-09-08 |
1993-10-12 |
Cygnus Therapeutic Systems |
Solid matrix system for transdermal drug delivery
|
|
JP3218637B2
(ja)
|
1990-07-26 |
2001-10-15 |
大正製薬株式会社 |
安定なリポソーム水懸濁液
|
|
JP2958076B2
(ja)
|
1990-08-27 |
1999-10-06 |
株式会社ビタミン研究所 |
遺伝子導入用多重膜リポソーム及び遺伝子捕捉多重膜リポソーム製剤並びにその製法
|
|
CA2091152C
(en)
|
1993-03-05 |
2005-05-03 |
Kirsten Westesen |
Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
|
|
JPH07285863A
(ja)
|
1994-02-25 |
1995-10-31 |
Takeda Chem Ind Ltd |
注射剤組成物およびその製造方法
|
|
ES2078190B1
(es)
|
1994-05-20 |
1996-08-01 |
Cusi Lab |
Procedimiento para el recubrimiento de goticulas o particulas de tamaño nanometrico.
|
|
US5741516A
(en)
|
1994-06-20 |
1998-04-21 |
Inex Pharmaceuticals Corporation |
Sphingosomes for enhanced drug delivery
|
|
US5795587A
(en)
|
1995-01-23 |
1998-08-18 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
US5697899A
(en)
|
1995-02-07 |
1997-12-16 |
Gensia |
Feedback controlled drug delivery system
|
|
US5510118A
(en)
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
|
US5738868A
(en)
|
1995-07-18 |
1998-04-14 |
Lipogenics Ltd. |
Liposome compositions and kits therefor
|
|
US5656016A
(en)
|
1996-03-18 |
1997-08-12 |
Abbott Laboratories |
Sonophoretic drug delivery system
|
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
|
US5783208A
(en)
|
1996-07-19 |
1998-07-21 |
Theratech, Inc. |
Transdermal drug delivery matrix for coadministering estradiol and another steroid
|
|
US5779708A
(en)
|
1996-08-15 |
1998-07-14 |
Cyberdent, Inc. |
Intraosseous drug delivery device and method
|
|
CA2264482A1
(en)
|
1996-09-06 |
1998-03-12 |
The Trustees Of The University Of Pennsylvania |
An inducible method for production of recombinant adeno-associated viruses utilizing t7 polymerase
|
|
US6007856A
(en)
|
1997-08-08 |
1999-12-28 |
The Procter & Gamble Company |
Oil-in-water dispersions of β-carotene and other carotenoids stable against oxidation prepared from water-dispersible beadlets having high concentrations of carotenoid
|
|
DE59914485D1
(de)
|
1998-03-30 |
2007-10-18 |
Mibelle Ag Cosmetics |
Verwendung von Nanoemulsionen zur Bestimmung der Biokompatibilität von lipophilen Stoffen im Zellkultur-Test und dafür geeignete Nanoemulsionen
|
|
US6436392B1
(en)
|
1998-05-20 |
2002-08-20 |
University Of Iowa Research Foundation |
Adeno-associated virus vectors
|
|
US8026096B1
(en)
|
1998-10-08 |
2011-09-27 |
Protein Sciences Corporation |
In vivo active erythropoietin produced in insect cells
|
|
PT1144009E
(pt)
|
1998-12-03 |
2003-01-31 |
Avigen Inc |
Excipientes para uso em formulacoes farmaceuticas a base de virus adeno-associado e formulacoes farmaceuticas produzidas com estes excipientes
|
|
FR2787728B1
(fr)
|
1998-12-23 |
2001-01-26 |
Oreal |
Nanoemulsion a base d'esters gras d'acide phosphorique, et ses utilisations dans les domaines cosmetique, dermatologique, pharmaceutique et/ou ophtalmologique
|
|
US6258595B1
(en)
|
1999-03-18 |
2001-07-10 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for helper-free production of recombinant adeno-associated viruses
|
|
WO2001025253A2
(en)
|
1999-10-01 |
2001-04-12 |
The University Of North Carolina At Chapel Hill |
Temperature-sensitive regulation of viral vector production
|
|
US7208315B2
(en)
|
2000-01-05 |
2007-04-24 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for efficient AAV vector production
|
|
WO2001066782A1
(en)
|
2000-03-03 |
2001-09-13 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adeno-associated viral compositions and methods
|
|
CA2403704C
(en)
|
2000-03-23 |
2012-04-10 |
Collaborative Technologies, Inc. |
Method for preparing high pressure/high shear dispersions containing physiologically active ingredients
|
|
AU4445701A
(en)
*
|
2000-03-24 |
2001-10-03 |
Centre National De La Recherche Scientifique-Cnrs |
Multiple human and mouse otoferlin isoforms
|
|
RS49646B
(sr)
|
2000-07-04 |
2007-09-21 |
Slobodan Arsenijević |
Instrument za ubrizgavanje fluida i dilataciona sonda za uvođenje u telesne šupljine
|
|
FR2811561B1
(fr)
|
2000-07-13 |
2003-03-21 |
Oreal |
Composition, notamment cosmetique, renfermant la dhea et/ou un precurseur ou derive chimique ou biologique de celle-ci, et un inhibiteur de metalloproteinase
|
|
US6329181B1
(en)
|
2000-08-07 |
2001-12-11 |
Neurologix, Inc. |
Helper functions for recombinant vector production
|
|
US6593123B1
(en)
|
2000-08-07 |
2003-07-15 |
Avigen, Inc. |
Large-scale recombinant adeno-associated virus (rAAV) production and purification
|
|
US20040048836A1
(en)
|
2001-03-23 |
2004-03-11 |
Wilmott James M |
Method for preparing high pressure/ high shear dispersions containing physiologically active ingredients
|
|
EP1377255A4
(en)
|
2001-03-30 |
2008-11-19 |
Color Access Inc |
NEW NANOEMULSIONS
|
|
KR100463167B1
(ko)
|
2001-04-13 |
2004-12-23 |
주식회사 태평양 |
고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
|
|
EP2545937A1
(en)
|
2001-06-05 |
2013-01-16 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
|
EP1427835B1
(en)
|
2001-08-08 |
2016-01-20 |
The Trustees of the University of Pennsylvania |
Method for purification of viral vectors having proteins which bind sialic acid
|
|
US20040115159A1
(en)
|
2002-03-29 |
2004-06-17 |
Tadlock Charles C |
Novel nanoemulsions
|
|
US7071172B2
(en)
|
2002-04-30 |
2006-07-04 |
The University Of North Carolina At Chapel Hill |
Secretion signal vectors
|
|
US7419817B2
(en)
|
2002-05-17 |
2008-09-02 |
The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. |
Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography
|
|
ATE389675T1
(de)
|
2002-09-12 |
2008-04-15 |
3M Innovative Properties Co |
Fluorelastomere mit niedertemperatureigenschaften und lösungsmittelbeständigkeit
|
|
US7329688B2
(en)
|
2002-12-17 |
2008-02-12 |
Soft Gel Technologies, Inc. |
Natural vitamin E compositions with superior antioxidant potency
|
|
JP4559429B2
(ja)
|
2003-05-21 |
2010-10-06 |
ジェンザイム・コーポレーション |
空キャプシドを実質的に含まない組換えaavビリオン調製物を生成するための方法
|
|
EP1633322A2
(en)
|
2003-06-04 |
2006-03-15 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
|
|
WO2005009287A2
(en)
|
2003-07-21 |
2005-02-03 |
University Of Maryland, Baltimore |
Drug delivery to the inner ear and methods of using same
|
|
US20060151899A1
(en)
|
2003-08-06 |
2006-07-13 |
Akira Kato |
Process for producing drug ultramicroparticle and apparatus therefor
|
|
EP1510206A1
(en)
|
2003-08-29 |
2005-03-02 |
Novagali Pharma SA |
Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs
|
|
CA2543722C
(en)
|
2003-10-29 |
2011-01-04 |
Sonus Pharmaceuticals, Inc. |
Tocopherol-modified therapeutic drug compounds
|
|
US7557197B2
(en)
|
2004-01-28 |
2009-07-07 |
Oregon Health & Science University |
Human soluble neuropilin-1 primary polyadenylation signal and uses thereof
|
|
MXPA06009529A
(es)
|
2004-02-23 |
2007-04-10 |
Texas A & M Univ Sys |
Composiciones antioxidantes y metodos para el uso de las mismas.
|
|
US7419497B2
(en)
|
2004-04-21 |
2008-09-02 |
Acclarent, Inc. |
Methods for treating ethmoid disease
|
|
ES2932278T3
(es)
|
2004-06-01 |
2023-01-17 |
Genzyme Corp |
Composiciones y métodos para prevenir la agregación del vector AAV
|
|
US20050281786A1
(en)
|
2004-06-18 |
2005-12-22 |
David Poulsen |
AAV mediated gene delivery to cochlear cells
|
|
WO2006012414A2
(en)
|
2004-07-20 |
2006-02-02 |
Critical Therapeutics, Inc. |
Novel polyadenylation signal for use in expression vectors
|
|
US8591457B2
(en)
|
2005-08-10 |
2013-11-26 |
Alza Corporation |
Method for making a needle-free jet injection drug delivery device
|
|
PT3272872T
(pt)
|
2005-10-20 |
2020-06-26 |
Uniqure Ip Bv |
Vetores aav melhorados produzidos em células de insetos
|
|
CN101528916B
(zh)
|
2006-04-28 |
2013-09-04 |
宾夕法尼亚大学托管会 |
规模可调的aav生产方法
|
|
US7851196B2
(en)
|
2006-05-01 |
2010-12-14 |
The Regents Of The University Of California |
Methods for purifying adeno-associated virus particles
|
|
WO2007148971A2
(en)
|
2006-06-21 |
2007-12-27 |
Amsterdam Molecular Therapeutics B.V. |
Vectors with modified initiation codon for the translation of aav-rep78 useful for production of aav in insect cells
|
|
US20080065002A1
(en)
|
2006-09-07 |
2008-03-13 |
Neurosystec Corporation |
Catheter for Localized Drug Delivery and/or Electrical Stimulation
|
|
US8173792B2
(en)
*
|
2007-02-09 |
2012-05-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method for regulating protein function in cells using synthetic small molecules
|
|
HUE029744T2
(en)
|
2007-07-26 |
2017-04-28 |
Uniqure Ip Bv |
Baculoviral vectors comprising repeated coding sequences with differential codon biases
|
|
US20090042825A1
(en)
|
2007-08-06 |
2009-02-12 |
Majed Matar |
Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer
|
|
US8236557B2
(en)
|
2008-05-28 |
2012-08-07 |
University Of Missouri-Columbia |
Hybrid-AAV vectors to deliver large gene expression cassette
|
|
CA2744976C
(en)
|
2008-11-28 |
2017-09-12 |
Austria Wirtschaftsservice Gesellschaft Mbh |
Artificial chromosome vector
|
|
JP5956331B2
(ja)
|
2009-06-16 |
2016-07-27 |
ジェンザイム・コーポレーション |
組換えaavベクターの改良された精製方法
|
|
JP5697123B2
(ja)
|
2009-07-27 |
2015-04-08 |
国立大学法人 千葉大学 |
酸性化ポリエチレンイミンを用いる細胞への核酸導入方法
|
|
WO2011075838A1
(en)
|
2009-12-21 |
2011-06-30 |
Audigen Inc. |
Method of treating or preventing hearing loss
|
|
EP2529020B1
(en)
|
2010-01-28 |
2018-04-25 |
The Children's Hospital of Philadelphia |
A scalable manufacturing platform for viral vector purification and viral vectors so purified for use in gene therapy
|
|
EP2545165B1
(en)
|
2010-03-11 |
2020-07-29 |
uniQure IP B.V. |
Mutated rep encoding sequences for use in aav production
|
|
EP2605761A1
(fr)
|
2010-08-19 |
2013-06-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Dispositif implantable dans l'os temporal pour administrer un produit et prothèse auditive pourvue d'un tel dispositif.
|
|
EP2500434A1
(en)
|
2011-03-12 |
2012-09-19 |
Association Institut de Myologie |
Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery
|
|
US8852165B2
(en)
|
2011-06-16 |
2014-10-07 |
II Edward G. Mackay |
Endoluminal drug delivery devices and methods
|
|
EP2771455B1
(en)
|
2011-10-28 |
2016-10-05 |
The University of North Carolina At Chapel Hill |
Cell line for production of adeno-associated virus
|
|
WO2013075008A1
(en)
|
2011-11-16 |
2013-05-23 |
University Of Florida Research Foundation Inc. |
Aav dual vector systems for gene therapy
|
|
BR112014020325A2
(pt)
|
2012-02-17 |
2017-08-08 |
Childrens Hospital Philadelphia |
composições de vetor do aav e métodos para a transferência de gene para as células, órgãos e tecidos
|
|
US11332719B2
(en)
|
2013-03-15 |
2022-05-17 |
The Broad Institute, Inc. |
Recombinant virus and preparations thereof
|
|
JP2016517278A
(ja)
*
|
2013-03-15 |
2016-06-16 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィアThe Children’S Hospital Of Philadelphia |
スタッファー/フィラーポリヌクレオチド配列を含むベクターおよびその使用方法
|
|
DK2986635T3
(en)
*
|
2013-04-18 |
2019-01-28 |
Fond Telethon |
EFFECTIVE DELIVERY OF BIG GENES THROUGH DUAL-AAV VECTORS
|
|
US11078464B2
(en)
|
2013-08-30 |
2021-08-03 |
Amgen Inc. |
High titer recombinant AAV vector production in adherent and suspension cells
|
|
HUE052676T2
(hu)
|
2013-10-11 |
2021-05-28 |
Massachusetts Eye & Ear Infirmary |
Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik
|
|
WO2015137802A1
(en)
|
2014-03-10 |
2015-09-17 |
Uniqure Ip B.V. |
Further improved aav vectors produced in insect cells
|
|
US10526583B2
(en)
|
2014-07-02 |
2020-01-07 |
University Of Florida Research Foundation, Incorporated |
Compositions and methods for purifying recombinant adeno-associated virus
|
|
SG11201704919SA
(en)
|
2015-01-13 |
2017-07-28 |
Alfa Wassermann Inc |
Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav)
|
|
EP3054006A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification with multiple-step anion exchange chromatography
|
|
US10751385B2
(en)
|
2015-02-20 |
2020-08-25 |
Institut Pasteur |
Prevention and/or treatment of hearing loss or impairment
|
|
CA2979120A1
(en)
*
|
2015-03-03 |
2016-09-09 |
Fondazione Telethon |
Multiple aav vector system for expressing genes over 5 kilobases, comprising at least one degradation signal and uses thereof
|
|
US20180043034A1
(en)
|
2015-03-06 |
2018-02-15 |
Massachusetts Eye And Ear Infirmary |
Gene augmentation therapies for inherited retinal degeneration caused by mutations in the prpf31 gene
|
|
EP4134375A1
(en)
|
2015-07-30 |
2023-02-15 |
Massachusetts Eye & Ear Infirmary |
Ancestral adeno associated virus sequences and uses thereof
|
|
EP3384015A4
(en)
|
2015-12-01 |
2019-05-29 |
Spark Therapeutics, Inc. |
SCALABLE PROCESS FOR THE PREPARATION OF A RECOMBINANT ADENO ASSOCIATED VIRAL VECTOR IN A SERUM-FREE SUSPENSION CELL CULTURE SYSTEM SUITABLE FOR THE CLINICAL APPLICATION
|
|
CA3007476A1
(en)
|
2015-12-11 |
2017-06-15 |
Massachusetts Eye And Ear Infirmary |
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
|
|
EP3393522B1
(en)
|
2015-12-22 |
2021-07-07 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Improved hybrid dual recombinant aav vector systems for gene therapy
|
|
CN109219439B
(zh)
|
2016-01-29 |
2022-09-20 |
马萨诸塞眼科耳科诊所 |
内耳支持细胞的扩增和分化及其使用方法
|
|
WO2017136764A1
(en)
|
2016-02-05 |
2017-08-10 |
The General Hospital Corporation |
Hybrid system for efficient gene delivery to cells of the inner ear
|
|
EP3474941A1
(en)
|
2016-06-22 |
2019-05-01 |
The Charles Stark Draper Laboratory, Inc. |
A system for inner ear drug delivery via trans-round window membrane injection
|
|
GB201612248D0
(en)
|
2016-07-14 |
2016-08-31 |
Puridify Ltd |
New process
|
|
AU2017299779B2
(en)
|
2016-07-21 |
2021-12-02 |
Spark Therapeutics, Inc. |
Scalable high recovery methods for producing high yield recombinant adeno-associated viral (rAAV) vector and recombinant adeno-associated viral (rAAV) vectors produced thereby
|
|
JP6994018B2
(ja)
|
2016-07-26 |
2022-01-14 |
バイオマリン ファーマシューティカル インコーポレイテッド |
新規アデノ随伴ウイルスキャプシドタンパク質
|
|
WO2018039375A1
(en)
|
2016-08-23 |
2018-03-01 |
Akouos, Inc. |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
PL3535388T3
(pl)
|
2016-11-04 |
2023-08-14 |
Takeda Pharmaceutical Company Limited |
Sposoby oczyszczania wirusów związanych z adenowirusami
|
|
US10626376B2
(en)
|
2016-11-14 |
2020-04-21 |
St. Jude Children's Research Hospital |
Method for isolating and purifying adeno-associated virus particles using salt
|
|
CN111698975A
(zh)
|
2017-02-06 |
2020-09-22 |
儿童医疗中心有限公司 |
将核酸递送至耳蜗和前庭细胞的材料和方法
|
|
EP3618839A4
(en)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS OF TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
|
|
US12359221B2
(en)
*
|
2017-05-05 |
2025-07-15 |
The Regents Of The University Of California |
Compositions and methods for expressing otoferlin
|
|
US20200270635A1
(en)
|
2017-05-05 |
2020-08-27 |
Voyager Therapeutics, Inc. |
Modulatory polynucleotides
|
|
MX2019013172A
(es)
|
2017-05-05 |
2020-09-07 |
Voyager Therapeutics Inc |
Composiciones y metodos para tratar la enfermedad de huntington.
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
US11512327B2
(en)
|
2017-08-03 |
2022-11-29 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of AAV
|
|
WO2019084145A1
(en)
|
2017-10-25 |
2019-05-02 |
The Charles Stark Draper Laboratory Inc. |
APPARATUS AND METHOD FOR DRUG DELIVERY ACROSS THE ROUND WINDOW MEMBRANE
|
|
EP3740581A4
(en)
|
2018-01-16 |
2021-10-27 |
CLS Therapeutics Limited |
TREATMENT OF DISEASES BY LIVER EXPRESSION OF AN ENZYME WITH DESOXYRIBONUCLEASE (DNASE) ACTIVITY
|
|
BR112020016059A2
(pt)
|
2018-02-09 |
2020-12-08 |
Decibel Therapeutics, Inc. |
Composições farmacêuticas hipertônicas contendo um agente quimioprotetor anti-platina
|
|
DE102018103924A1
(de)
|
2018-02-21 |
2019-08-22 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Gentherapeutische Behandlung von Schwerhörigkeit
|
|
IL325122A
(en)
|
2018-02-22 |
2026-02-01 |
Akouos Inc |
Compositions and methods for treating non-age-related hearing impairment in humans
|
|
JP7430652B2
(ja)
|
2018-03-05 |
2024-02-13 |
ザ チルドレンズ メディカル センター コーポレーション |
蝸牛および前庭細胞に核酸を送達するための組成物および方法
|
|
US11660353B2
(en)
|
2018-04-27 |
2023-05-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
CN112703016B
(zh)
|
2018-04-27 |
2024-11-22 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
WO2019222329A1
(en)
|
2018-05-15 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
CN112424359A
(zh)
|
2018-05-15 |
2021-02-26 |
沃雅戈治疗公司 |
用于治疗帕金森氏病的组合物和方法
|
|
MX2020013953A
(es)
|
2018-07-11 |
2021-03-09 |
Takeda Pharmaceuticals Co |
Composiciones de virus adenoasociado (aav).
|
|
WO2020023612A1
(en)
|
2018-07-24 |
2020-01-30 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
|
US12491223B2
(en)
|
2018-09-27 |
2025-12-09 |
Akouos, Inc. |
Method for treating an auditory neuropathy spectrum disorder
|
|
US12534739B2
(en)
|
2018-10-11 |
2026-01-27 |
Decibel Therapeutics, Inc. |
AAV1 vectors and uses thereof for treatment of otic indications
|
|
WO2020093018A1
(en)
|
2018-11-01 |
2020-05-07 |
University Of Florida Research Foundation, Incorporated |
A codon optimized otoferlin aav dual vector gene therapy
|
|
CN113853437A
(zh)
|
2018-11-07 |
2021-12-28 |
阿库斯股份有限公司 |
腺相关病毒载体用于在内耳中的毛细胞和支持细胞中校正基因缺陷/表达蛋白质的用途
|
|
CN113924109A
(zh)
|
2019-01-18 |
2022-01-11 |
巴斯德研究所 |
Aav介导的基因疗法恢复耳畸蛋白基因
|
|
CN110437317B
(zh)
|
2019-01-30 |
2023-05-02 |
上海科技大学 |
具有变异衣壳蛋白的腺相关病毒及其用途
|
|
WO2020163761A1
(en)
|
2019-02-08 |
2020-08-13 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
|
EP3921032A4
(en)
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
|
|
WO2020223933A1
(zh)
|
2019-05-08 |
2020-11-12 |
中国科学院脑科学与智能技术卓越创新中心 |
高效感染支持细胞的aav突变体
|
|
JP7713130B2
(ja)
|
2019-09-30 |
2025-07-25 |
イーライ リリー アンド カンパニー |
遺伝性難聴の処置のためのアデノ随伴ウイルス(aav)システム
|
|
AU2020366531A1
(en)
|
2019-10-18 |
2022-05-26 |
Research Institute At Nationwide Children's Hospital |
Gene therapy targeting cochlear cells
|
|
TWI896570B
(zh)
|
2019-10-30 |
2025-09-11 |
美商迪賽博治療公司 |
使用耳畸蛋白雙載體系統治療感覺神經性聽力損失之組合物及方法
|
|
EP4054653A4
(en)
|
2019-11-04 |
2023-11-29 |
Decibel Therapeutics, Inc. |
PROMOTERS OF COCHLEAR EXTERNAL HAIR CELLS AND THEIR USES
|
|
CA3157799A1
(en)
|
2019-11-11 |
2021-05-20 |
Salk Institute For Biological Studies |
Compositions and methods for high-efficiency recombination of rna molecules
|
|
WO2021150850A1
(en)
|
2020-01-24 |
2021-07-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Svcs. |
Adeno-associated viruses and their uses for inner ear therapy
|
|
EP4100533A1
(en)
|
2020-02-07 |
2022-12-14 |
University of Rochester |
Ribozyme-mediated rna assembly and expression
|
|
US20230090778A1
(en)
|
2020-02-07 |
2023-03-23 |
The Children's Medical Center Corporation |
Large gene vectors and delivery and uses thereof
|
|
CA3168055A1
(en)
|
2020-02-21 |
2021-08-26 |
Emmanuel John Simons |
Compositions and methods for treating non-age-associated hearing impairment in a human subject
|
|
WO2021183825A1
(en)
|
2020-03-12 |
2021-09-16 |
California Institute Of Technology |
Adeno-associated viral capsids with expanded sizes
|
|
CN111349148A
(zh)
|
2020-03-13 |
2020-06-30 |
辉大(上海)生物科技有限公司 |
一种腺相关病毒载体及其用途
|
|
EP3885440A1
(en)
|
2020-03-26 |
2021-09-29 |
Splicebio, S.L. |
Split inteins and their uses
|
|
WO2022056440A1
(en)
|
2020-09-14 |
2022-03-17 |
President And Fellows Of Harvard College |
Dual-aav vector delivery of pcdh15 and uses thereof
|
|
MX2023005344A
(es)
|
2020-11-06 |
2023-12-07 |
Lilly Co Eli |
Polipéptidos de la cápside variante del virus adenoasociado (aav) y su terapéutico génica para el tratamiento de la pérdida de audición.
|
|
EP4008788A1
(en)
|
2020-12-03 |
2022-06-08 |
Medizinische Hochschule Hannover |
Lentiviral vector technology for inner ear gene therapy
|
|
KR20240004253A
(ko)
|
2021-02-19 |
2024-01-11 |
데시벨 테라퓨틱스, 인크. |
오토펄린 듀얼 벡터 시스템을 사용한 감각신경성 난청을 치료하기 위한 방법
|
|
US20240226331A9
(en)
|
2021-02-22 |
2024-07-11 |
Decibel Therapeutics, Inc. |
Methods and compositions for reducing nucleic acid vector-induced toxicity in the inner ear
|
|
AU2022264006A1
(en)
|
2021-04-27 |
2023-11-02 |
The Children's Hospital Of Philadelphia |
Adeno-associated viral vectors for transduction of cochlea
|
|
WO2023283962A1
(en)
|
2021-07-16 |
2023-01-19 |
Huigene Therapeutics Co., Ltd. |
Modified aav capsid for gene therapy and methods thereof
|
|
CN113337507B
(zh)
|
2021-08-05 |
2021-11-12 |
首都医科大学附属北京友谊医院 |
Otof 1273 (C>T)基因定点突变的耳聋小鼠模型的构建方法及其应用
|
|
JP2024534991A
(ja)
|
2021-09-10 |
2024-09-26 |
インスティチュート パスツール |
オトフェリンのアイソフォーム5をコードする二重組換えaav8ベクター系およびその使用
|
|
US20250099619A1
(en)
|
2021-12-06 |
2025-03-27 |
Juntendo Educational Foundation |
Modified adeno-associated virus vector
|
|
JP2025504263A
(ja)
|
2021-12-23 |
2025-02-10 |
ユニバーシティ オブ ロチェスター |
内耳への薬剤の送達のためのcsf輸送経路
|
|
CN117106824B
(zh)
|
2022-05-17 |
2025-09-02 |
上海佑音医药生物科技有限公司 |
一种治疗听力损伤的双载体系统及其应用
|
|
US20230242942A1
(en)
|
2022-05-17 |
2023-08-03 |
Eye & Ent Hospital Of Fudan University |
Dual-vector system for treating hearing impairment and use thereof
|
|
AR129387A1
(es)
|
2022-05-19 |
2024-08-21 |
Akouos Inc |
Composiciones y métodos para el tratamiento de deficiencias auditivas no asociadas a la edad en un sujeto humano
|
|
WO2024151703A2
(en)
|
2023-01-12 |
2024-07-18 |
Ohio State Innovation Foundation |
Gene therapy for treating hearing loss disorders
|
|
CN121002049A
(zh)
|
2023-02-17 |
2025-11-21 |
分贝治疗公司 |
用于施用耳畸蛋白双载体系统的方法和组合物
|
|
CN120882872A
(zh)
|
2023-03-17 |
2025-10-31 |
罗切斯特大学 |
核酶介导的rna组装和表达
|
|
CN118834869A
(zh)
|
2023-04-12 |
2024-10-25 |
上海玮美基因科技有限责任公司 |
Senp6启动子及其用途
|
|
CN121311586A
(zh)
|
2023-05-12 |
2026-01-09 |
苏州星奥拓维生物技术有限公司 |
耳蜗內毛细胞特异性启动子及其应用
|
|
WO2024239226A1
(zh)
|
2023-05-23 |
2024-11-28 |
苏州星奥拓维生物技术有限公司 |
耳蜗毛细胞特异性启动子及其用途
|
|
WO2025003513A1
(en)
|
2023-06-29 |
2025-01-02 |
Katholieke Universiteit Leuven |
Otoferlin gene transfer
|
|
CN116925239B
(zh)
|
2023-07-17 |
2024-10-18 |
苏州星奥拓维生物技术有限公司 |
双载体系统表达Otof基因的组合物和方法
|
|
CN117305367A
(zh)
|
2023-08-21 |
2023-12-29 |
复旦大学附属眼耳鼻喉科医院 |
一种表达全长耳畸蛋白的双aav载体系统及其应用
|
|
KR20260092437A
(ko)
|
2023-10-19 |
2026-06-18 |
유니버시티 오브 피츠버그-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 |
난청 및 전정 장애를 위한 유전자 요법
|
|
AU2024397647A1
(en)
|
2023-12-11 |
2026-06-25 |
Akouos, Inc. |
Compositions and methods for treating hearing loss in a human subject having a defective otoferlin gene
|
|
CN118931896A
(zh)
|
2024-04-09 |
2024-11-12 |
复旦大学附属眼耳鼻喉科医院 |
一种用于修复OTOF基因p.Q829X突变的单碱基编辑系统及其应用
|
|
CN118667036B
(zh)
|
2024-08-20 |
2025-01-10 |
上海玮美基因科技有限责任公司 |
一种融合型腺相关病毒衣壳蛋白、腺相关病毒及其应用
|
|
CN120098142A
(zh)
|
2025-03-06 |
2025-06-06 |
东南大学 |
腺嘌呤碱基编辑器用于dfnb9听力损失修复
|